Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a version update to the page rendering. No study details or functionality are modified.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Taiwan site entry was updated from 'Taoyuan, Taiwan, 33305' to 'Taoyuan City, Taiwan, 33305' to reflect the correct administrative designation for the Taoyuan location in the study's locations.SummaryDifference0.0%

- Check36 days agoChange DetectedA site interface revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page revision entry was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.